HPV vaccines offer hope against HPV-associated cancers for males and females; however, the rate of vaccination has not reached projected public health goals. This study will engage key stakeholders in the research process to co-design and pilot testing a video-based intervention addressing low HPV vaccination rates among college students The intervention and its approach have the potential to reduce health disparities in HPV-associated cancers in young adults via low-cost technology and timely intervention.
Age range
18 Years – 26 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Participants' HPV vaccination intention
Timeframe: through study completion, an average of 1 year
Participants' HPV vaccine uptake
Timeframe: through study completion, an average of 1 year
Participants' attitude toward receiving the HPV vaccines
Timeframe: through study completion, an average of 1 year
Participants' subjective norms
Timeframe: through study completion, an average of 1 year
Participants' perceived behavioral controls
Timeframe: through study completion, an average of 1 year
Participants' satisfaction
Timeframe: through study completion, an average of 1 year